Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|May 19, 1988
Anagrelide: a new drug for treating thrombocytosisM N Silverstein, R M Petitt, L A Solberg, et al.
British Journal of Cancer|March 20, 2021
Does a high Mandard score really define a poor response to chemotherapy in oesophageal adenocarcinoma?William R C Knight, Cara R Baker, Nyree Griffin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 21, 2020
Endoscopic tumour morphology impacts survival in adenocarcinoma of the oesophagusWilliam R C Knight, Ricardo McEwen, Ben E Byrne, et al.
European Journal of Immunology|December 1, 1989
Heterogeneity in the ability of IgG1 monoclonal anti-D to promote lymphocyte-mediated red cell lysisB M Kumpel, K A Leader, A H Merry, et al.
Blood|September 1, 1995
Human Rh D monoclonal antibodies (BRAD-3 and BRAD-5) cause accelerated clearance of Rh D+ red blood cells and suppression of Rh D immunization in Rh D- volunteersB M Kumpel, M J Goodrick, D H Pamphilon, et al.
Cognition & Emotion|October 2, 2024
Investigation of the mental health and cognitive correlates of psychological decentering in adolescenceR C Knight, D L Dunning, J Cotton, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|February 8, 2021
Analysis of outcomes of a transoral circular stapled anastomosis following major upper gastrointestinal cancer resectionDaniel M Foley, Emudiaga J E Emanuwa, William R C Knight, et al.
BJS Open|August 7, 2018
Impact of incremental circumferential resection margin distance on overall survival and recurrence in oesophageal adenocarcinomaW R C Knight, J Zylstra, W Wulaningsih, et al.
BJS Open|June 29, 2018
Patterns of recurrence in oesophageal cancer following oesophagectomy in the era of neoadjuvant chemotherapyW R C Knight, J Zylstra, M Van Hemelrijck, et al.
Acta Oncologica (Stockholm, Sweden)|October 6, 2021
Predicting response to neoadjuvant chemotherapy in patients with oesophageal adenocarcinomaRebecca K Bott, Gincy George, Ricardo McEwen, et al.
Pageof 5